Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
Hematologic Oncology Update
Patient Experience and Management of Side Effects
Exploring the experience of a patient receiving CD20 x CD3 bispecific antibodies and discussing the precautions, symptom management, and support system needed for treatment. Also, comparing different treatment approaches for lymphoma.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
